Through homemade maps, CityLab readers shared perspectives and stories from a world transformed by the coronavirus pandemic.
Through homemade maps, CityLab readers shared perspectives and stories from a world transformed by the coronavirus pandemic.
No one yet has good answers to these questions. Kristen V. Brown looked into what we do, and don’t, know about the science of coronavirus immunity.
Michelle Fay Cortez and Olivia Carville report that it’s not yet clear what the long-term consequences ventilators have for those lucky enough to recover after having been on one.
Emma Court reports on the difficult choices doctors are forced to make, and the danger that we’re creating another health care crisis.
Historically, the U.S. Centers for Disease control and Prevention has been the agency in charge of predicting, and containing outbreaks of disease. But as Covid 19 ravaged the country, the agency took a backseat to the White House.
Michelle Fay Cortez and John Tozzi discuss how the agency has handled the pandemic response, its early missteps, and how its role is likely to change in the future.
Scientists around the world are racing to develop a vaccine for COVID-19. But experts have said it could take a year to 18 months for one to hit the market. The process for testing and approving a vaccine is long and complicated.
That can be frustrating when the coronavirus is taking more and more lives every day. But cutting corners to push a vaccine through faster can lead to devastating consequences. We know that, because it’s happened before.
Mar.03 — World Health Organization spokesman Tarik Jasarevic speaks from Geneva about the latest advice for avoiding the coronavirus. He also comments on efforts to develop a vaccine and advice for public health workers. He speaks on “Bloomberg Markets: European Open.”
Feb.18 — In the series “EVs: The Brink of Change”, Bloomberg’s Alix Steel breaks down electric vehicles – what’s in them, how they work, their range, and cost of certain models.
Paul Robin Krugman (born February 28, 1953) is an American economist who is the Distinguished Professor of Economics at the Graduate Center of the City University of New York, and a columnist for The New York Times. In 2008, Krugman was awarded the Nobel Memorial Prize in Economic Sciences for his contributions to New Trade Theory and New Economic Geography. The Prize Committee cited Krugman’s work explaining the patterns of international trade and the geographic distribution of economic activity, by examining the effects of economies of scale and of consumer preferences for diverse goods and services.
Krugman was previously a professor of economics at MIT, and later at Princeton University. He retired from Princeton in June 2015, and holds the title of professor emeritus there. He also holds the title of Centenary Professor at the London School of Economics. Krugman was President of the Eastern Economic Association in 2010, and is among the most influential economists in the world. He is known in academia for his work on international economics (including trade theory and international finance),economic geography, liquidity traps, and currency crises.
Krugman is the author or editor of 27 books, including scholarly works, textbooks, and books for a more general audience, and has published over 200 scholarly articles in professional journals and edited volumes. He has also written several hundred columns on economic and political issues for The New York Times, Fortune and Slate. A 2011 survey of economics professors named him their favorite living economist under the age of 60.[13] As a commentator, Krugman has written on a wide range of economic issues including income distribution, taxation, macroeconomics, and international economics. Krugman considers himself a modern liberal, referring to his books, his blog on The New York Times, and his 2007 book The Conscience of a Liberal. His popular commentary has attracted widespread attention and comments, both positive and negative. According to the Open Syllabus Project, Krugman is the second most frequently cited author on college syllabi for economics courses.
From Wikipedia
This week on Prognosis, we look at one startup that’s trying to redesign care for some of the most vulnerable patients, taking into account the complex realities of their lives. The company is trying to improve care for people and communities the medical system often fails – and it believes that fixing those failures will not only make people healthier, it will also save money.
In America, poverty is linked to shorter lifespans. The wealthiest 1% of Americans live more than a decade longer than the poorest 1%, and the longevity gap has expanded in recent years. The medical community is increasingly examining the role that poverty and difficult social circumstances play in illness. Some people are asking whether the health care system could do more to address the things that influence people’s health beyond their medical care.